ARMP · AMEX
Armata Pharmaceuticals (ARMP) Stock Price & Fundamentals
Armata Pharmaceuticals (ARMP) closed at $771.33 on Oct 9, 2026, up 0.91% from the previous close of $764.39.
Share price, past year
1Y +49.89%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $771.33 |
| Sep 30, 2026 | $768.68 |
| Aug 31, 2026 | $762.52 |
| Jul 31, 2026 | $728.25 |
| Jun 30, 2026 | $674.80 |
| May 29, 2026 | $679.40 |
| Apr 30, 2026 | $680.02 |
| Mar 31, 2026 | $651.53 |
| Feb 27, 2026 | $638.70 |
| Jan 30, 2026 | $620.14 |
| Dec 31, 2025 | $604.29 |
| Nov 28, 2025 | $553.36 |
| Oct 31, 2025 | $507.84 |
Key statistics
- Market cap
- $28.65B
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- —
- Net income (TTM)
- −$192.18M
- Shares outstanding
- 37.1M
- Dividend yield
- —
- 52-week range
- $499.72 – $774.12
Armata Pharmaceuticals's market cap is $28.65B, based on a share price of $771.33 and 37.1M shares outstanding as of Jun 30, 2026.
Financials
Armata Pharmaceuticals reported revenue of $409.00K for fiscal 2014, up 404.94% from fiscal 2013.
Armata Pharmaceuticals reported a net loss of $173.80M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2014ended Dec 31, 2014 | $409.00K | +404.9% | — | — | — | — |
| FY2013ended Dec 31, 2013 | $81.00K | — | — | — | — | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2020ended Jun 30, 2020 | $31.00K | — | — |
| Q1 FY2015ended Mar 31, 2015 | $102.00K | — | — |
| Q4 FY2014ended Dec 31, 2014 | $101.00K | — | — |
| Q3 FY2014ended Sep 30, 2014 | $103.00K | — | — |
| Q2 FY2014ended Jun 30, 2014 | $101.00K | — | — |
| Q1 FY2014ended Mar 31, 2014 | $104.00K | — | — |
| Q4 FY2013ended Dec 31, 2013 | −$252.00K | — | — |
| Q3 FY2013ended Sep 30, 2013 | −$3.00K | — | — |
Company profile
- Name
- Armata Pharmaceuticals, Inc.
- Ticker
- ARMP
- Exchange
- AMEX
- Industry (SEC SIC)
- Biological Products, (No Diagnostic Substances)
- Headquarters
- 5005 Mcconnell Ave, Los Angeles, CA 90066
- Incorporated in
- WA
- Fiscal year ends
- December
- SEC CIK
- 0000921114
Recent SEC filings
- Sep 23, 2026
- Sep 14, 2026
- Aug 12, 2026
- Aug 12, 2026
- Jul 20, 2026
- Jul 20, 2026
- Jul 13, 2026
- Jun 23, 2026
Frequently asked questions
What is Armata Pharmaceuticals's stock price?
Armata Pharmaceuticals (ARMP) closed at $771.33 on Oct 9, 2026, up 0.91% from the previous close of $764.39.
What is Armata Pharmaceuticals's market cap?
Armata Pharmaceuticals's market cap is $28.65B, based on a share price of $771.33 and 37.1M shares outstanding as of Jun 30, 2026.
How much revenue does Armata Pharmaceuticals make?
Armata Pharmaceuticals reported revenue of $409.00K for fiscal 2014, up 404.94% from fiscal 2013.
Does Armata Pharmaceuticals pay a dividend?
Armata Pharmaceuticals's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Armata Pharmaceuticals, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures